See full press release - by TeleDaas, on Nov 26, 2023
We are thrilled to announce the launch of TeleDaaS, PLLC, a pioneering medical practice that will revolutionize the radiopharmaceutical industry by providing Dosimetry-as-a-Service. A team of leading dosimetry practitioners will leverage Mirada’s proprietary software to support clinical research organizations in clinical trial design, execution, and the development of new targeted radiation therapies.
Accelerating cancer care internationally is the shared goal of Mirada and TeleDaaS, and we look forward to transforming cancer care by increasing access to the effective use of radiopharmaceuticals.
To find out more, see the full Press Release here
